The British Medical is reporting on a study that links high potency statin drugs with acute kidney injury.
The Canadian study concludes that the “use of high potency statins is associated with an increased rate of diagnosis for acute kidney injury in hospital admissions compared with low potency cholesterol-lowering drugs. The effect seems to be strongest in the first 120 days after initiation of statin treatment.”
The study was designed as a retrospective observational analysis of administrative databases and involved data from 7 Canadian databases, 1 UK and 1 US database. In all, information from 2 067 639 patients aged 40 years or older was examined and matched with 10 controls.
The report concludes that the risk of renal injury from high potency statins seems strongest in the first 120 days of treatment.
